Funded Startups in Magdeburg
Magdeburg’s most recently disclosed financing shows a sharp size split: Solar Materials raised $18M on 2026-04-22, while the next-largest disclosed rounds…
Magdeburg’s most recently disclosed financing shows a sharp size split: Solar Materials raised $18M on 2026-04-22, while the next-largest disclosed rounds are $10M (Neotiv, 2022-11-09) and $2M (byte robotics, 2025-06-02; Infinite Devices, 2020-05-27), with several entries undisclosed (eversyn on 2024-01-01 and InLine-Med on 2022-08-03). The disclosed amounts therefore cluster heavily at the sub-$2M to $2M range, making the $18M round a clear outlier in this snapshot.
Across the 9 rows shown, the rounds span 2020-05-27 (Infinite Devices) to 2026-04-22 (Solar Materials), with a noticeable “recent window” in 2025–2026: 3 of 9 entries fall in 2025–2026 (byte robotics on 2025-06-02; Benefits-Manager AG on 2026-02-23; Solar Materials on 2026-04-22). Sector-wise, Biotechnology appears in 3 entries (eversyn, Neotiv, InLine-Med), while funding stage classifications are split between named stages and unknowns: 2 of 9 rows show “undisclosed” amounts and 2 of 9 rows list a blank stage (“mycrocast” in 2020-11-12 and “Infinite Devices” in 2020-05-27).
Most recent rounds
9 shownRelated listings
Frequently asked
Which disclosed round is largest in this Magdeburg list, and how separated is it from the rest of the disclosed amounts?
Solar Materials’ $18M round (2026-04-22) is the only disclosed amount above $10M. The next-largest disclosed rounds are $10M (Neotiv, 2022-11-09) and $2M (byte robotics, 2025-06-02; Infinite Devices, 2020-05-27), with multiple entries undisclosed (eversyn on 2024-01-01; InLine-Med on 2022-08-03).
Do the most recent investments cluster into a narrow time window?
Yes. Three of the 9 rows have round dates in 2025–2026: byte robotics (Seed, 2025-06-02, $2M), Benefits-Manager AG (Seed, 2026-02-23, $590K), and Solar Materials (Series B, 2026-04-22, $18M). The overall date span for the displayed rows runs from 2020-05-27 (Infinite Devices) to 2026-04-22 (Solar Materials).
Are any sectors over-represented, based on repeats across these 9 rows?
Biotechnology is the clearest repeat sector, appearing in 3 of 9 entries: eversyn (Seed, 2024-01-01, undisclosed), Neotiv (Seed, 2022-11-09, $10M), and InLine-Med (Seed, 2022-08-03, undisclosed). Other sectors (e.g., Energy, Hardware, AI, Manufacturing, Media and Entertainment, Data and Analytics) appear once each in the rows shown.
What does the stage labeling suggest: do named stages dominate, or do unknown/blank fields show up often?
Named stages do not dominate exclusively. Two rows have undisclosed amounts (eversyn on 2024-01-01; InLine-Med on 2022-08-03), and two rows have blank stage fields (“mycrocast” on 2020-11-12, $200K; “Infinite Devices” on 2020-05-27, $2M). The remaining rows include Seed (e.g., Benefits-Manager AG at $590K on 2026-02-23; byte robotics at $2M on 2025-06-02) and Series B (Solar Materials at $18M on 2026-04-22).
Which entries look like outliers beyond deal size, such as sector differences or missing disclosures?
Beyond the size outlier ($18M Solar Materials on 2026-04-22), the main disclosure outliers are sector-adjacent but amount-blank rows: eversyn (Biotechnology, 2024-01-01, Seed, undisclosed) and InLine-Med (Other, 2022-08-03, Seed, undisclosed). In contrast, the list includes smaller disclosed rounds like Urwahn Engineering’s $100K (Venture - Series Unknown, 2022-02-16) alongside larger but disclosed $2M rounds (byte robotics in 2025 and Infinite Devices in 2020).
Know which startups just got funded. Every week.
Fresh funding rounds, new companies, and the sectors moving fastest — in your inbox every Monday morning.
Free. Sent every Monday. Unsubscribe anytime.